NO20056029L - Fremgangsmate for screening etter inhibitorer av gammasekretase - Google Patents

Fremgangsmate for screening etter inhibitorer av gammasekretase

Info

Publication number
NO20056029L
NO20056029L NO20056029A NO20056029A NO20056029L NO 20056029 L NO20056029 L NO 20056029L NO 20056029 A NO20056029 A NO 20056029A NO 20056029 A NO20056029 A NO 20056029A NO 20056029 L NO20056029 L NO 20056029L
Authority
NO
Norway
Prior art keywords
gamma
secretase
protein
cell
val
Prior art date
Application number
NO20056029A
Other languages
English (en)
Other versions
NO334058B1 (no
Inventor
Luc Mercken
Ekkehard Leberer
Jonathan Rothblatt
Edmund Hoppe
Gisela Peraus
Sylvie Dreisler
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of NO20056029L publication Critical patent/NO20056029L/no
Publication of NO334058B1 publication Critical patent/NO334058B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/61—Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/71—Fusion polypeptide containing domain for protein-protein interaction containing domain for transcriptional activaation, e.g. VP16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/80—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor
    • C07K2319/81—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor containing a Zn-finger domain for DNA binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Plant Pathology (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

Oppfinnelsen vedrører en forbedret prosess for bestemmelsen av (-sekretaseaktiviteten, individuelle komponenter i prosessen og anvendelsen av prosessen. Den foreliggende oppfinnelsen vedrører en forbedret prosess for bestemmelsen av (-sekretaseaktiviteten og for deteksjonen av (-sekretase, et subenhetsprotein av (-sekretase, eller en (-sekretaselignende proteinase. Bestemte utførelsesformer av prosessen vedrører på den ene siden prosesser for identifiseringen av en (-sekretase eller av et cDNA som koder for en (-sekretase, et subenhetsprotein og (-sekretase eller en (-sekretaselignende proteinase og på den andre siden til prosesser for å identifisere substanser som kan hemme aktiviteten av en (-sekretase, et subenhetsprotein av (-sekretase eller en (-sekretaselignende protease. Slike substanser har spesiell viktighet ettersom de kan anvendes for eksempel som farmasøytisk aktive forbindelser, for eksempel for behandlingen av Alzheimers sykdom.
NO20056029A 2003-05-26 2005-12-19 Prosess for deteksjon av gammasekretase aktivitet samt anvendelse derav NO334058B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP20030011807 EP1481987A1 (en) 2003-05-26 2003-05-26 Method for screening inhibitors of the gamma-secretase
PCT/EP2004/004550 WO2004104037A1 (en) 2003-05-26 2004-04-29 Method for screening inhibitors of the gamma-secretase

Publications (2)

Publication Number Publication Date
NO20056029L true NO20056029L (no) 2006-02-24
NO334058B1 NO334058B1 (no) 2013-12-02

Family

ID=33104072

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20056029A NO334058B1 (no) 2003-05-26 2005-12-19 Prosess for deteksjon av gammasekretase aktivitet samt anvendelse derav

Country Status (17)

Country Link
US (1) US7892778B2 (no)
EP (2) EP1481987A1 (no)
JP (1) JP4903046B2 (no)
KR (1) KR101215855B1 (no)
CN (1) CN1795203B (no)
AT (1) ATE393779T1 (no)
AU (1) AU2004241151B2 (no)
BR (1) BRPI0410736A (no)
CA (1) CA2526790C (no)
DE (1) DE602004013440T2 (no)
DK (1) DK1631584T3 (no)
ES (1) ES2307012T3 (no)
IL (1) IL172119A (no)
MX (1) MXPA05012663A (no)
NO (1) NO334058B1 (no)
RU (1) RU2373284C2 (no)
WO (1) WO2004104037A1 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007028655A2 (en) * 2005-09-09 2007-03-15 H. Lundbeck A/S Drug discovery for neurodevelopmental disorders and their complications
WO2007030937A2 (en) * 2005-09-16 2007-03-22 Institut De Recherches Cliniques De Montreal/I.R.C.M. Screening proteinase modulators using a chimeric protein and ski-i proprotein convertase substrates and inhibitors
KR100883158B1 (ko) * 2005-10-26 2009-02-10 주식회사 뉴젝스 살아있는 세포에서 단백질분해효소의 활성 측정 방법
JP2007300856A (ja) * 2006-05-11 2007-11-22 Hiroshi Mori アミロイドタンパク質模倣物
WO2008061673A2 (en) * 2006-11-24 2008-05-29 Synthon B.V. Drug discovery for cancer
CN104880441B (zh) * 2015-05-14 2017-12-22 上海皓拓生物技术有限公司 β‑分泌酶特异性抑制剂的筛选方法及其筛选系统
WO2017041037A1 (en) * 2015-09-04 2017-03-09 The Trustees Of Columbia University In The City Of New York Disruption of the interaction between amyloid beta peptide and dietary lipids

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07132033A (ja) * 1993-11-12 1995-05-23 Hoechst Japan Ltd アルツハイマー病モデルトランスジェニック動物
WO1998015828A1 (en) * 1996-10-07 1998-04-16 Scios Inc. Method to identify direct inhibitors of the beta-amyloid forming enzyme gamma-secretase
DE19849073A1 (de) * 1998-10-24 2000-04-27 Aventis Pharma Gmbh Transgener C. elegans als Modellorganismus für Untersuchungen zur Alzheimer'schen Krankheit
DE19856261C1 (de) * 1998-12-07 2000-03-30 Hoechst Marion Roussel De Gmbh Aß-Peptid Screening Assay
DE19920514A1 (de) * 1999-05-05 2000-11-16 Boehringer Ingelheim Pharma Methoden zur Auffindung von Proteasen, die spezifisch membrangebundene Substrate spalten
JP4362035B2 (ja) * 2001-05-11 2009-11-11 メディカル リサーチ カウンシル Ｒｈｏｍｂｏｉｄポリペプチドのモジュレーターを同定するアッセイ

Also Published As

Publication number Publication date
EP1631584B1 (en) 2008-04-30
WO2004104037A1 (en) 2004-12-02
CA2526790A1 (en) 2004-12-02
CN1795203B (zh) 2010-06-16
ES2307012T3 (es) 2008-11-16
NO334058B1 (no) 2013-12-02
EP1631584A1 (en) 2006-03-08
JP4903046B2 (ja) 2012-03-21
EP1481987A1 (en) 2004-12-01
AU2004241151B2 (en) 2009-04-09
US7892778B2 (en) 2011-02-22
DK1631584T3 (da) 2008-09-01
KR20060015312A (ko) 2006-02-16
CN1795203A (zh) 2006-06-28
KR101215855B1 (ko) 2012-12-31
HK1091215A1 (en) 2007-01-12
CA2526790C (en) 2013-12-24
BRPI0410736A (pt) 2006-06-27
US20050032150A1 (en) 2005-02-10
RU2373284C2 (ru) 2009-11-20
DE602004013440D1 (de) 2008-06-12
AU2004241151A1 (en) 2004-12-02
RU2005140567A (ru) 2006-06-27
MXPA05012663A (es) 2006-05-25
ATE393779T1 (de) 2008-05-15
JP2008502302A (ja) 2008-01-31
DE602004013440T2 (de) 2009-05-20
IL172119A (en) 2010-12-30

Similar Documents

Publication Publication Date Title
Pappano et al. Use of Bmp1/Tll1 doubly homozygous null mice and proteomics to identify and validate in vivo substrates of bone morphogenetic protein 1/tolloid-like metalloproteinases
Srivastava et al. Proteolytic processing of a precursor protein for a growth‐promoting peptide by a subtilisin serine protease in Arabidopsis
Chapman et al. Emerging roles for cysteine proteases in human biology
ATE471373T1 (de) Expression von endogenen genen durch homologe rekombination eines vektorkonstruktes mit zellulärer dna
Dolmatov et al. Molecular mechanisms of fission in echinoderms: Transcriptome analysis
Price et al. A venom metalloproteinase from the parasitic wasp Eulophus pennicornis is toxic towards its host, tomato moth (Lacanobia oleracae)
Bown et al. Characterization of a digestive carboxypeptidase from the insect pest corn earworm (Helicoverpa armigera) with novel specificity towards C‐terminal glutamate residues
ES2531167T3 (es) Amilasas y glucoamilasas, ácidos nucleicos que las codifican y métodos para formarlas y utilizarlas
NO331251B1 (no) Faktor VII-polypeptidvariant, nukleinsyrekonstruksjon, rekombinant vertscelle, ikke-humant transgent dyr, fremgangsmate for fremstilling av faktor VII-poly¬peptidet, samt anvendelse av et faktor VII-polypeptid til fremstilling av et medi¬kament for behandling av blodningsepisoder
NO20056029L (no) Fremgangsmate for screening etter inhibitorer av gammasekretase
Marelja et al. The four aldehyde oxidases of Drosophila melanogaster have different gene expression patterns and enzyme substrate specificities
Jiang et al. Differential neuropeptidomes of dense core secretory vesicles (DCSV) produced at intravesicular and extracellular pH conditions by proteolytic processing
DE60117761D1 (de) Luciferase, fluoreszenzproteine, für luciferase und fluoreszenzproteine kodierend nukleinsaüre und ihre verwendung in der diagnose, hoch-durchsatz screeningsverfahren
ATE236259T1 (de) Herstellung einzelner genprodukte eines chimären fusionsproteins durch spaltung mit überall vorkommenden endoproteasen
Goupil et al. Cysteine and aspartyl proteases contribute to protein digestion in the gut of freshwater planaria
Brennan et al. Molecular mechanisms of hypo‐and afibrinogenemia
Spanier et al. Caenorhabditis elegans neprilysin NEP-1: an effector of locomotion and pharyngeal pumping
Elpidina et al. Digestive peptidases in Tenebrio molitor and possibility of use to treat celiac disease
Miller et al. The role of upstream sequences in selecting the reading frame on tmRNA
Wood et al. Defining substrate requirements for cleavage of farnesylated prelamin A by the integral membrane zinc metalloprotease ZMPSTE24
Min et al. Identification of peptide inhibitors of matrix metalloproteinase 1 using an in-house assay system for the enzyme
ATE445009T1 (de) Signalpeptid zur herstellung eines polypeptids
Velayos-Baeza et al. The function of chorein
Hartmann et al. The N-terminal region of the α-subunit of the TRAP complex has a conserved cluster of negative charges
Macours et al. An endothelin‐converting enzyme homologue in the locust, Locusta migratoria: functional activity, molecular cloning and tissue distribution

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees